ISPC · XBRL financial data
iSpecimen financial statements, every fiscal year
The same tables from 6 filings, lined up. Matched by XBRL tag: renamed lines keep their history.
How these numbers work
- Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
- Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
- * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
- 0 means a filing states zero; a dash (—) means no filing states that number.
- “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
- Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
- Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
- Shares outstanding come from each filing's cover page, as of the date printed there.
- Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.
Income statement
CSVFiscal years (ISPC's year ends in late December)
| In thousands of dollars | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | †Dec 31, 2024 | †Dec 31, 2025 |
|---|---|---|---|---|---|
| Revenue | — | — | 9,928 | 9,291 | 1,929 |
| Revenue from contracts with customers | 11,135 | 10,402 | 9,928 | — | — |
| Cost of revenue | — | — | 4,771 | 5,111 | 1,713 |
| Cost of goods and services sold | 5,249 | 4,757 | 4,820 | 5,303 | 1,905 |
| Research and development | 295 | 1,474 | 1,619 | 1,493 | — |
| General and administrative | 5,613 | 6,933 | 5,935 | 6,067 | 3,472 |
| Operating income (loss) | (5,925) | (10,186) | (11,169) | (12,728) | (8,978) |
| Interest income | 11 | — | — | 44 | 4 |
| Interest expense | 2,103 | 239 | 16 | 174 | 2 |
| Other income (expense) | (3,037) | 10 | (39) | 406 | (1,503) |
| Income tax expense (benefit) | 0 | 0 | — | — | — |
| Net income (loss) | (8,962) | (10,246) | (11,099) | (12,498) | (10,488) |
| Earnings per share, basic‡ USD per share | (836.00) | (464.00) | (492.00) | (17.58) | (2.28) |
| Earnings per share, diluted‡ USD per share | (836.00) | (464.00) | (492.00) | (17.58) | (2.28) |
| Weighted average shares, basic‡ thousands of shares | 11 | 22 | 23 | 711 | 4,602 |
| Weighted average shares, diluted‡ thousands of shares | 11 | 22 | 23 | 711 | 4,602 |
- ‡ Per-share figures and share counts are adjusted for the 1-for-20 stock split (September 2024); filings made before it reported them unadjusted.
- ‡ Per-share figures and share counts are adjusted for the 1-for-20 stock split (October 2024); filings made before it reported them unadjusted.
- † Share count changed about 110x in the period ending 2024-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
- † Share count changed about 12x in the period ending 2025-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
Balance sheet
CSVFiscal years (ISPC's year ends in late December)
| In thousands of dollars | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | †Dec 31, 2024 | †Dec 31, 2025 |
|---|---|---|---|---|---|
| Cash and cash equivalents | 27,739 | 15,309 | 2,344 | 1,878 | 6,881 |
| Marketable securities | — | 0 | 2,662 | — | — |
| Accounts receivable | 3,002 | 1,598 | 728 | 1,445 | 48 |
| Inventory | — | — | — | 45 | — |
| Prepaid and other current assets | 327 | 300 | 292 | 265 | 25 |
| Total current assets | 32,948 | 19,676 | 8,239 | 3,588 | 6,955 |
| Property and equipment, net | 33 | 226 | 128 | 94 | 26 |
| Right-of-use asset | — | 185 | 194 | 328 | 269 |
| Total assets | 35,720 | 24,618 | 15,819 | 9,350 | 9,531 |
| Accounts payable | 833 | 2,459 | 3,925 | 4,198 | 5,363 |
| Accrued liabilities | 1,010 | 1,531 | 1,541 | 1,169 | 619 |
| Total current liabilities | 2,505 | 4,281 | 6,049 | 5,770 | 6,231 |
| Lease liability, non-current | — | 27 | 29 | 269 | 212 |
| Total liabilities | 5,928 | 4,308 | 6,078 | 6,039 | 6,443 |
| Accumulated deficit | (38,019) | (48,265) | (59,365) | (71,863) | (82,350) |
| Total stockholders' equity | 29,792 | 20,309 | 9,741 | 3,311 | 3,088 |
| Total liabilities and equity | 35,720 | 24,618 | 15,819 | 9,350 | 9,531 |
| Common shares outstanding (cover page)‡ thousands of shares | 22 | 23 | 23 | 2,497 | 29,662 |
- ‡ Per-share figures and share counts are adjusted for the 1-for-20 stock split (September 2024); filings made before it reported them unadjusted.
- ‡ Per-share figures and share counts are adjusted for the 1-for-20 stock split (October 2024); filings made before it reported them unadjusted.
- † Share count changed about 110x in the period ending 2024-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
- † Share count changed about 12x in the period ending 2025-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
Cash flows
CSVFiscal years (ISPC's year ends in late December)
| In thousands of dollars | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | †Dec 31, 2024 | †Dec 31, 2025 |
|---|---|---|---|---|---|
| Net income (loss) | (8,962) | (10,246) | (11,099) | (12,498) | (10,488) |
| Stock-based compensation | 622 | 679 | 460 | 250 | 21 |
| Net cash from operating activities | (10,668) | (5,818) | (5,808) | (8,264) | (4,241) |
| Purchases of property and equipment | 3 | 216 | 19 | 32 | 0 |
| Net cash from investing activities | (1,038) | (3,191) | (7,228) | 1,980 | (1,000) |
| Proceeds from issuing common stock | 18,000 | — | — | 398 | 4,000 |
| Proceeds from issuing equity | — | — | — | 398 | — |
| Proceeds from long-term debt | 3,500 | — | — | — | — |
| Net cash from financing activities | 38,749 | (3,421) | 71 | 5,819 | 10,243 |
- † Share count changed about 110x in the period ending 2024-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
- † Share count changed about 12x in the period ending 2025-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
Compare with peers
SIC 8731 and related industry codes, similar size. Each row is the latest quarter reported.
How peers are chosen
- SIC 8731 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
- Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
- Runway shows only for companies burning cash with under $10B of public float.
- * marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
- A cell reading “not reported” means the filings give no figure for that quarter alone.
| Company | Cash ($K) | Revenue, quarter ($K) | Operating cash flow, quarter ($K) | Shares outstanding | Runway | Quarter |
|---|---|---|---|---|---|---|
| iSpecimen | 4,414 | 152 | (690)* | 2.5M | 6.4 quarters | 10-QJun 30, 2026 |
| Cannabis Bioscience International Holdings | 0.1 | 11 | (15)* | 11.6B | 0.0 quarters | 10-QFeb 28, 2026 |
| Hypha Labs | 5.1 | not reported | (52)* | 163.9M | 0.1 quarters | 10-QJun 30, 2026 |
| Foxo Technologies | 58 | 4,715 | 299* | 1.7M | — | 10-QJun 30, 2026 |
| Weed | 1.1 | 0 | (19)* | 148.3M | 0.1 quarters | 10-QJun 30, 2026 |
Not investment advice. Not affiliated with the U.S. SEC.